Translating Duke Health (TDH) initiative is taking a deep look both into the human brain and across the human lifespan. Basic and translational research scientists across Duke are working to unravel the secrets of the human brain to discover new therapies and harness the brain’s own capacity for resilience and self-repair.  

A team at Duke Health has performed what is believed to be the world’s first partial heart transplant, with the living arteries and valves from a freshly donated heart fused onto a patient’s existing heart.

When NASA’s Artemis I mission launches later this year, its crew will include Helga and Zohar, two manikin models designed in collaboration with Duke University. The manikins will collect valuable data about the radiation levels astronauts face as they travel through space

Duke University President Vincent E. Price visited Duke’s clinical research office at the North Carolina Research Campus in Kannapolis today. Duke Kannapolis demonstrates Duke’s commitment to advancing community health and improving lives across the state.

The Duke Center for Autism and Brain Development has been awarded a $12 million federal grant to develop artificial intelligence tools for detecting autism during infancy and identifying brain-based biomarkers of autism.

Duke’s commitment to partnerships across the state took four undergraduate global health majors to Pamlico County this summer. There they worked to address health disparities and disaster readiness.

A new Duke Cancer Institute research program co-led by Meira Epplein, PhD, and Katharine Garman, MD, brings together physicians, cancer biologists, epidemiologists, and biostatisticians to develop new ways to identify people at increased risk of cancer — specifically stomach cancer in Black community populations — and to “intercept” the disease before it has a chance to become established.

Health systems face elevated threats from cyberattacks. A new perspective piece written by Duke Clinical Research Institute Chief Science and Digital Officer Eric Perakslis, PhD, and published in the New England Journal of Medicine (NEJM) offers a clinicians’ guide to cybersecurity. In “Responding to the Escalating Cybersecurity Threat in Health Care,” Perakslis offers actionable insights to help health care providers protect themselves and their patients from the threats of cyberattacks.

Senior author Ann Marie Pendergast, Ph.D., and researchers from Duke Cancer Institute found a drug approved to treat leukemia successfully disrupted the ability of HER2-positive breast cancer tumors from colonizing the brain.

A new study comparing discharged COVID-19 hospital patients to discharged patients who were hospitalized for other reasons showed the COVID patients were 45% more likely to experience heart failure within a year following their discharge.